Levetiracetam Biomo

Levetiracetam, the active ingredient in Levetiracetam Biomo, is an anticonvulsant presented as an oral dosage form for oral use. It belongs to the antiepileptic drug class and is prescribed to manage various seizure types in patients with epilepsy, including partial‑onset, generalized tonic‑clonic, and myoclonic seizures.

GNH USA supplies Levetiracetam Biomo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, providing reliable sourcing for regulated markets. The company adheres to stringent quality standards and offers comprehensive logistics support.

Levetiracetam is an antiepileptic medication that reduces neuronal excitability in seizure disorders.

Partial‑onset seizures: reduces frequency of focal seizures in patients with epilepsy. Generalized tonic‑clonic seizures: helps control convulsive episodes in generalized epilepsy. Myoclonic seizures: decreases myoclonic jerks in appropriate patient populations.

Levetiracetam may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of lightheadedness or unsteadiness. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate cranial pain. - Irritability: increased mood swings or agitation.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood or behavior changes: depression, suicidal thoughts, or aggression. - Blood disorders: signs of low blood cell counts such as bruising or infections.

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure patient safety.

- Renal function: adjust dose in patients with impaired renal clearance. - Psychiatric history: monitor for mood alterations or suicidal ideation. - Concomitant CNS depressants: use caution as additive sedation may occur. - Pregnancy status: evaluate risks versus benefits before use. - Driving and operating machinery: advise patients about possible dizziness or drowsiness. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Levetiracetam can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels, decreasing effectiveness. - Phenobarbital: can lower levetiracetam concentrations, potentially compromising seizure control.

Moderate Interactions (Monitor Closely): - Alcohol: combined use may enhance central nervous system depression. - Sedative antihistamines: may increase drowsiness when taken together. - Other antiepileptic drugs: monitor for additive side effects or altered seizure control.